Vor Biopharma VOR
NASDAQ VOR
$18.90 +0.84 (+4.65%)
As of: Oct 2, 2026 · 10:19 AM EDT

Vor Biopharma (VOR) Return on Assets [ROA] (2021 - 2026)

Updated

Vor Biopharma (VOR) reported Return on Assets [ROA] of -27.19% for Q2 2026, up 204.48 percentage points from -231.66% a year earlier and up 47.90 percentage points from the prior quarter.

Analysis

Vor Biopharma (VOR) Return on Assets [ROA] (2021 - 2026) Analysis & Trends

For FY2025, Vor Biopharma posted Return on Assets [ROA] of -120.52%, down 51.95 percentage points from FY2024.

  • Return on Assets [ROA] has declined for three consecutive years, with a four-year change of -77.25 percentage points (FY2021 to FY2025).
  • By year, Return on Assets [ROA] came in at -68.57% in FY2024 (-21.18 pp), -47.38% in FY2023 (-13.40 pp), -33.99% in FY2022 (+9.28 pp) and -43.26% in FY2021.
  • The Q2 2026 figure ranks as the highest quarterly Return on Assets [ROA] since Q3 2021.
  • Year over year, Return on Assets [ROA] gained in two of the last eight quarters, with an average year-over-year change of -19.98 percentage points.
  • The high point for year-over-year Return on Assets [ROA] in five years was Q2 2026 (a gain of 204.48 percentage points); the low point was Q2 2025 (a drop of 155.13 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -75.09% (Q1 2026), -114.24% (Q4 2025) and -190.42% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 Vor Biopharma 1.04 Bn 1.04 Bn - -27.19%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -27.19%
Mar 31, 2026 -75.09%
Dec 31, 2025 -114.24%
Sep 30, 2025 -190.42%
Jun 30, 2025 -231.66%
Mar 31, 2025 -94.05%
Dec 31, 2024 -90.32%
Sep 30, 2024 -87.32%
Jun 30, 2024 -76.53%
Mar 31, 2024 -65.85%
Dec 31, 2023 -55.97%
Sep 30, 2023 -48.74%
Jun 30, 2023 -40.15%
Mar 31, 2023 -33.90%
Dec 31, 2022 -36.42%
Sep 30, 2022 -40.11%
Jun 30, 2022 -35.39%
Mar 31, 2022 -32.68%
Dec 31, 2021 -27.49%
Sep 30, 2021 -24.85%
API Access

Vor Biopharma Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=VOR&period=max&api_key=YOUR_API_KEY